Zydus Cadila in talks to sell two units for Rs 1,200 crore

This is part of a broader strategy to reduce debt in the company’s capital structure after it borrowed more to help finance the Rs 4,600-crore acquisition earlier this year of Heinz India’s consumer wellness business. Zydus has approached larger rivals, such as Cipla and Sun Pharmaceutical Industries, besides financial investors.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37gbfvp
via IFTTT